What do systematic reviews say?

Improvement in central macular thickness on OCT · participants with acute or chronic CME following cataract surgery

Improved contrast sensitivity · participants with acute or chronic CME following cataract surgery

QoL · participants with acute or chronic CME following cataract surgery

Persistence of visual improvement one month after discontinuation of treatment · participants with acute CME (< 4 months) following cataract surgery

Improvement in central macular thickness on OCT · participants with acute CME (< 4 months) following cataract surgery

QoL · participants with acute CME (< 4 months) following cataract surgery

Induction of labour · people with multifocal motor neuropathy

Induction of labour · people with multifocal motor neuropathy

Maintenance · people with multifocal motor neuropathy

Proportion of IVIg‐treated participants with an increase in disability during controlled IVIg withdrawal · people with multifocal motor neuropathy

Adverse events · people with multifocal motor neuropathy

Proportion of participants with an improvement in disability at 12 months or later · people with multifocal motor neuropathy

Maintenance · people with multifocal motor neuropathy

Primary outcomes · patients with stroke

Secondary seizure prophylaxis after stroke · patients with stroke

Secondary outcomes · patients with stroke

Recurrence of ARTI · children aged up to 16 years with ARTIs

Days off work for parents · children aged up to 16 years with ARTIs

Need for antibiotics · children aged up to 16 years with ARTIs

Disease severity · children aged up to 16 years with ARTIs